High Risk Prostate Carcinoma Clinical Trials
0 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 2
Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone
Prostate CancerHigh Risk Prostate Carcinoma
Ivan de Kouchkovsky, MD32 enrolled1 locationNCT06384222
Recruiting
Phase 3
Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
Prostate CancerHigh Risk Prostate Carcinoma
UNICANCER700 enrolled6 locationsNCT06625970
Recruiting
Not Applicable
Towards Optimal Treatment for High Risk Prostate Cancer
High Risk Prostate Carcinoma
Haaglanden Medical Centre207 enrolled1 locationNCT06204341
Recruiting
Phase 2
Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)
High Risk Prostate Carcinoma
Samsung Medical Center33 enrolled1 locationNCT06461793